| Sanofis Kampfansage an Pfizer (Handelszeitung) |
| DealBook: Cavan M. Redmond of Pfizer to Oversee WebMD (EN, New York Times) |
| Outlooks for Pfizer, Arena and Onyx Following Busy May (EN, TheStreet.com) |
| Pfizer recalls Advil bottles from distributors (EN, Market Watch) |
| Pfizer, Glaxo, J&J Grab ASCO Spotlight (EN, TheStreet.com) |
| Pfizer in Transition (EN, MotleyFool) |
| Pfizer announces first-ever recipients of its Psychiatry Research Awards (EN, CNX) |
| A Much-Needed Win for Pfizer (EN, MotleyFool) |
| Chevron, GE, Pfizer: Dow Midday Movers (EN, TheStreet.com) |
| Ex-Dividend Stocks: Boeing, Wal-Mart, Pfizer (EN, TheStreet.com) |
| Medikament kaum wirksam: Neuer Forschungs-Rückschlag für Pfizer (Handelsblatt) |
| Lyrica wirkt unzureichend: Pfizer stoppt Studien (N-TV) |
| The Next Big Thing in Biotech: Pfizer (EN, TheStreet.com) |
| Pfizer Living Life after Lipitor (EN, MotleyFool) |
| Pfizer Looks Fine Post-Tornado (EN, MotleyFool) |
| Future of Pfizer: It's the R&D, Stupid! (EN, TheStreet.com) |
| Charges, generic Lipitor cut Pfizer Q1 profit by 19% (EN, Chinapost) |
| Pfizer: Gewinn im ersten Quartal rückläufig, Erwartungen geschlagen, Ausblick gesenkt (Aktiencheck) |
| Pfizer muss bittere Pille schlucken (ARD) |
| Pfizer Profit Declines 19% After Loss of Lipitor Patent (EN, New York Times) |
| Pfizer settles lawsuit over Celebrex for $450M; profit falls (EN, USA Today) |
| Pfizer Beats Analyst Estimates on EPS (EN, MotleyFool) |
| Earnings Fall at Post-Lipitor Pfizer (EN, The Wall Street Journal Deutschland) |
| Earnings Fall at Post-Lipitor Pfizer (EN, Barrons) |
| Pfizer hit by fall in Lipitor sales (EN, Financial Times) |
| Pfizer profits solid despite Lipitor loss (EN, Yahoo) |
| Pfizer Earnings Fall on Declining Lipitor Revenue (EN, Benzinga earnings) |
| Stocks Pause Ahead of Factory Data; BP, Pfizer Slip on Earnings (EN, Barrons) |
| Pharmakonzern: Pfizer leidet unter Nachahmer-Präparaten (Handelsblatt) |
| Stocks Pause Ahead of Factory Data; BP, Pfizer Slip on Earnings (EN, The Wall Street Journal Deutschland) |
| Pfizer leidet unter Generika (NZZ) |
| Pfizer leidet unter Generika (Handelszeitung) |
| Pharma: Pfizer leidet unter Generika (Blick) |
| Pfizer leidet unter Nachahmer-Präparaten (dpa-afx) |
| Pfizer cuts year outlook for earnings and revenue (EN, Market Watch) |
| Patent Expiration Weighs on Pfizer Earnings (EN, The Wall Street Journal Deutschland) |
| UPDATE: Pfizer Posts Upbeat Q1 Profit (EN, Benzinga earnings) |
| Pfizer 1st-period net off 19%, revenue down 6.6% (EN, Market Watch) |
| Pfizer Q1 profit falls 19 pct on generic Lipitor (EN, Yahoo) |
| Pfizer beats profit forecast, helped by cost cuts (EN, Reuters) |